Flamel Technologies (NASDAQ: FLML) announced that Professor Christian Trepo presented the results of its clinical trial of Flamel's Medusa formulation ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE